Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Growth (Status and Outlook) 2023-2029

Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Growth (Status and Outlook) 2023-2029

The isothermal nucleic acid amplification technology (INAAT) is used in molecular biology and recombinant DNA technologies for detecting and identifying nucleic acids. It is commonly used to amplify nucleic acids at a constant temperature, thereby eliminating the need for thermocycler equipment. Isothermal amplification of nucleic acids is a simple process that rapidly and efficiently accumulates nucleic acid sequences at constant temperature.
LPI (LP Information)' newest research report, the “Isothermal Nucleic Acid Amplification Technology (INAAT) Industry Forecast” looks at past sales and reviews total world Isothermal Nucleic Acid Amplification Technology (INAAT) sales in 2022, providing a comprehensive analysis by region and market sector of projected Isothermal Nucleic Acid Amplification Technology (INAAT) sales for 2023 through 2029. With Isothermal Nucleic Acid Amplification Technology (INAAT) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Isothermal Nucleic Acid Amplification Technology (INAAT) industry.
This Insight Report provides a comprehensive analysis of the global Isothermal Nucleic Acid Amplification Technology (INAAT) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Isothermal Nucleic Acid Amplification Technology (INAAT) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Isothermal Nucleic Acid Amplification Technology (INAAT) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Isothermal Nucleic Acid Amplification Technology (INAAT) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Isothermal Nucleic Acid Amplification Technology (INAAT).
The global Isothermal Nucleic Acid Amplification Technology (INAAT) market size is projected to grow from US$ 6141.3 million in 2022 to US$ 11250 million in 2029; it is expected to grow at a CAGR of 9.0% from 2023 to 2029.
Global key players of Isothermal Nucleic Acid Amplification Technology (INAAT) include Abbott, BioMerieux and Hologic, etc. Global top three manufacturers hold a share over 70%. North America is the largest market of Isothermal Nucleic Acid Amplification Technology (INAAT), with a share nearly 80%, followed by Europe.
This report presents a comprehensive overview, market shares, and growth opportunities of Isothermal Nucleic Acid Amplification Technology (INAAT) market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
LAMP
TMA
NEAR
NASBA
HDA
SPIA
Other
Segmentation by application
Medical Diagnostic
Scientific Research
Food Testing
Environmental Hygiene
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
BioMerieux
Hologic
BD
Grifols
Quidel
Meridian Bioscience
Qiagen
Eiken Chemical
OptiGene
HiberGene Diagnostic
Lucigen
Nippon Gene
Mast Group
New England Biolabs
Ustar Biotechnologies

Please note: The report will take approximately 2 business days to prepare and deliver.